We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$130B
AUM Growth
+$12.3B
Cap. Flow
+$1.54B
Cap. Flow %
1.18%
Top 10 Hldgs %
17.24%
Holding
8,628
New
1,223
Increased
3,315
Reduced
2,707
Closed
1,164

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$548M
2
MU icon
Micron Technology
MU
+$461M
3
C icon
Citigroup
C
+$334M
4
AVGO icon
Broadcom
AVGO
+$319M
5
ABBV icon
AbbVie
ABBV
+$267M

Sector Composition

Rank Sector Weight
1 Technology 7.23%
2 Financials 5.58%
3 Industrials 4.98%
4 Consumer Discretionary 4.95%
5 Healthcare 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRIP icon
6626
PUT
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$99.5M
$173K ﹤0.01%
+24
New +$231K
LXFR icon
6627
Luxfer Holdings
LXFR
$457M
$173K ﹤0.01%
+13,919
New +$174K
STAA icon
6628
STAAR Surgical
STAA
$1.3B
$172K ﹤0.01%
+13,836
New +$154K
UIS icon
6629
CALL
Unisys
UIS
$209M
$172K ﹤0.01%
20,200
-1,200
-6% -$11.6K
BLCM
6630
CALL
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$172K ﹤0.01%
1,490
+430
+41% +$45.2K
PGNX
6631
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$172K ﹤0.01%
23,317
-27,808
-54% -$177K
AMID
6632
PUT
DELISTED
American Midstream Partners, LP
AMID
$172K ﹤0.01%
12,600
-19,600
-61% -$264K
TGNA
6633
CALL
DELISTED
TEGNA Inc
TGNA
$171K ﹤0.01%
12,800
+2,500
+24% +$33.5K
USAC icon
6634
PUT
USA Compression Partners
USAC
$3.86B
$171K ﹤0.01%
10,200
-1,700
-14% -$27.4K
BWG
6635
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$130M
$170K ﹤0.01%
+12,664
New +$171K
IPI icon
6636
PUT
Intrepid Potash
IPI
$493M
$170K ﹤0.01%
3,890
+1,870
+93% +$63.1K
ISD
6637
PGIM High Yield Bond Fund
ISD
$414M
$170K ﹤0.01%
+11,111
New +$169K
ISEE
6638
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$170K ﹤0.01%
60,266
+20,051
+50% +$54.1K
EXTR icon
6639
CALL
Extreme Networks
EXTR
$3.2B
$169K ﹤0.01%
14,200
+3,100
+28% +$31.9K
RMTI icon
6640
PUT
Rockwell Medical
RMTI
$29.2M
$169K ﹤0.01%
180
-477
-73% -$365K
ATCO
6641
DELISTED
Atlas Corp.
ATCO
$169K ﹤0.01%
23,869
-44,823
-65% -$308K
CATO icon
6642
PUT
Cato Corp
CATO
$67.9M
$168K ﹤0.01%
+12,700
New +$190K
PEI
6643
CALL
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$168K ﹤0.01%
1,067
-566
-35% -$93.1K
DBRG icon
6644
PUT
DigitalBridge
DBRG
$2.94B
$167K ﹤0.01%
3,325
-10,250
-76% -$560K
LFC
6645
PUT
DELISTED
China Life Insurance Company Ltd.
LFC
$167K ﹤0.01%
11,100
-700
-6% -$11K
CDZI icon
6646
CALL
Cadiz
CDZI
$292M
$165K ﹤0.01%
13,000
-800
-6% -$9.74K
DHT icon
6647
DHT Holdings
DHT
$3.14B
$165K ﹤0.01%
41,511
-12,709
-23% -$51K
NGD
6648
DELISTED
New Gold Inc
NGD
$165K ﹤0.01%
44,359
-328,772
-88% -$1.14M
APLP
6649
PUT
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
$165K ﹤0.01%
11,600
+1,200
+12% +$16.9K
TIME
6650
PUT
DELISTED
Time Inc.
TIME
$165K ﹤0.01%
12,200
-7,300
-37% -$98K

Similar funds

Ken Griffin's Q3 2017 Portfolio in Review

As of Q3 2017, Ken Griffin held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ken Griffin's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.

By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.4% a quarter earlier, followed by Financials and Industrials.

  • Ken Griffin's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
  • Ken Griffin added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
  • Ken Griffin's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
  • Ken Griffin fully exited Citigroup in Q3 2017, selling an estimated $334M.
  • Ken Griffin's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
  • Ken Griffin opened 1,223 new positions and closed 1,164 in Q3 2017.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $130B.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.